rs755736125
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001458.5(FLNC):c.6325A>G(p.Ile2109Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000991 in 1,614,012 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001458.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FLNC | NM_001458.5 | c.6325A>G | p.Ile2109Val | missense_variant | Exon 38 of 48 | ENST00000325888.13 | NP_001449.3 | |
FLNC | NM_001127487.2 | c.6226A>G | p.Ile2076Val | missense_variant | Exon 37 of 47 | NP_001120959.1 | ||
FLNC-AS1 | NR_149055.1 | n.103-188T>C | intron_variant | Intron 1 of 3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152180Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000200 AC: 5AN: 249460 AF XY: 0.0000222 show subpopulations
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461832Hom.: 0 Cov.: 33 AF XY: 0.00000688 AC XY: 5AN XY: 727216 show subpopulations
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152180Hom.: 0 Cov.: 33 AF XY: 0.0000404 AC XY: 3AN XY: 74338 show subpopulations
ClinVar
Submissions by phenotype
Cardiovascular phenotype Uncertain:2
The p.I2109V variant (also known as c.6325A>G), located in coding exon 38 of the FLNC gene, results from an A to G substitution at nucleotide position 6325. The isoleucine at codon 2109 is replaced by valine, an amino acid with highly similar properties. This variant has been detected in an arrhythmogenic cardiomyopathy cohort; however, details were not provided (Celeghin R et al. Heart Rhythm. 2022 Feb;19(2):235-243). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
PM2, BP4 -
Myofibrillar myopathy 5;C3279722:Distal myopathy with posterior leg and anterior hand involvement;C4310749:Hypertrophic cardiomyopathy 26;CN239310:Dilated Cardiomyopathy, Dominant Uncertain:1
This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 2109 of the FLNC protein (p.Ile2109Val). This variant is present in population databases (rs755736125, gnomAD 0.004%). This missense change has been observed in individual(s) with clinical features of FLNC-related conditions (PMID: 34601126). ClinVar contains an entry for this variant (Variation ID: 574563). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at